342 related articles for article (PubMed ID: 29901257)
1. Machine Learning Classification Models to Improve the Docking-based Screening: A Case of PI3K-Tankyrase Inhibitors.
Berishvili VP; Voronkov AE; Radchenko EV; Palyulin VA
Mol Inform; 2018 Nov; 37(11):e1800030. PubMed ID: 29901257
[TBL] [Abstract][Full Text] [Related]
2. Development of Ligand-based Big Data Deep Neural Network Models for Virtual Screening of Large Compound Libraries.
Xiao T; Qi X; Chen Y; Jiang Y
Mol Inform; 2018 Nov; 37(11):e1800031. PubMed ID: 29882343
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors.
Zhou S; Li Y; Hou T
J Chem Inf Model; 2013 Apr; 53(4):982-96. PubMed ID: 23506306
[TBL] [Abstract][Full Text] [Related]
4. Identification of Novel PI3Kδ Selective Inhibitors by SVM-Based Multistage Virtual Screening and Molecular Dynamics Simulations.
Liang JW; Wang S; Wang MY; Li SL; Li WQ; Meng FH
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795217
[TBL] [Abstract][Full Text] [Related]
5. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
Gabel J; Desaphy J; Rognan D
J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
[TBL] [Abstract][Full Text] [Related]
6. In-Silico Molecular Binding Prediction for Human Drug Targets Using Deep Neural Multi-Task Learning.
Lee K; Kim D
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31703452
[TBL] [Abstract][Full Text] [Related]
7. Using machine learning to improve ensemble docking for drug discovery.
Chandak T; Mayginnes JP; Mayes H; Wong CF
Proteins; 2020 Oct; 88(10):1263-1270. PubMed ID: 32401384
[TBL] [Abstract][Full Text] [Related]
8. Selective and potent small-molecule inhibitors of PI3Ks.
Jeong Y; Kwon D; Hong S
Future Med Chem; 2014 May; 6(7):737-56. PubMed ID: 24941870
[TBL] [Abstract][Full Text] [Related]
9. Task-Specific Scoring Functions for Predicting Ligand Binding Poses and Affinity and for Screening Enrichment.
Ashtawy HM; Mahapatra NR
J Chem Inf Model; 2018 Jan; 58(1):119-133. PubMed ID: 29190087
[TBL] [Abstract][Full Text] [Related]
10. Protein Preparation Automatic Protocol for High-Throughput Inverse Virtual Screening: Accelerating the Target Identification by Computational Methods.
De Vita S; Lauro G; Ruggiero D; Terracciano S; Riccio R; Bifulco G
J Chem Inf Model; 2019 Nov; 59(11):4678-4690. PubMed ID: 31593460
[TBL] [Abstract][Full Text] [Related]
11. Discovering new PI3Kα inhibitors with a strategy of combining ligand-based and structure-based virtual screening.
Yu M; Gu Q; Xu J
J Comput Aided Mol Des; 2018 Feb; 32(2):347-361. PubMed ID: 29306979
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR, Virtual Screening, Docking and Design of Dual PI3K/mTOR Inhibitors with Enhanced Antiproliferative Activity.
Oluić J; Nikolic K; Vucicevic J; Gagic Z; Filipic S; Agbaba D
Comb Chem High Throughput Screen; 2017 Aug; 20(4):292-303. PubMed ID: 28460621
[TBL] [Abstract][Full Text] [Related]
13. Identification of small-molecule EGFR allosteric inhibitors by high-throughput docking.
Caporuscio F; Tinivella A; Restelli V; Semrau MS; Pinzi L; Storici P; Broggini M; Rastelli G
Future Med Chem; 2018 Jul; 10(13):1545-1553. PubMed ID: 29766737
[TBL] [Abstract][Full Text] [Related]
14. The current limits in virtual screening and property prediction.
Hutter MC
Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247
[TBL] [Abstract][Full Text] [Related]
15. Use of machine learning approaches for novel drug discovery.
Lima AN; Philot EA; Trossini GH; Scott LP; Maltarollo VG; Honorio KM
Expert Opin Drug Discov; 2016; 11(3):225-39. PubMed ID: 26814169
[TBL] [Abstract][Full Text] [Related]
16. Discovery of Novel Tankyrase Inhibitors through Molecular Docking-Based Virtual Screening and Molecular Dynamics Simulation Studies.
Berishvili VP; Kuimov AN; Voronkov AE; Radchenko EV; Kumar P; Choonara YE; Pillay V; Kamal A; Palyulin VA
Molecules; 2020 Jul; 25(14):. PubMed ID: 32664504
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel aminopyrazine series as selective PI3Kα inhibitors.
Barlaam B; Cosulich S; Fitzek M; Germain H; Green S; Hanson LL; Harris CS; Hancox U; Hudson K; Lambert-van der Brempt C; Lamorlette M; Magnien F; Ouvry G; Page K; Ruston L; Ward L; Delouvrié B
Bioorg Med Chem Lett; 2017 Jul; 27(13):3030-3035. PubMed ID: 28526367
[TBL] [Abstract][Full Text] [Related]
18. SCORCH: Improving structure-based virtual screening with machine learning classifiers, data augmentation, and uncertainty estimation.
McGibbon M; Money-Kyrle S; Blay V; Houston DR
J Adv Res; 2023 Apr; 46():135-147. PubMed ID: 35901959
[TBL] [Abstract][Full Text] [Related]
19. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
[TBL] [Abstract][Full Text] [Related]
20. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
